Form 4 Tracker
John Oyler

Director, Chief Executive Officer · 2 filings · Latest: Jun 8, 2026

BeOne Medicines Ltd.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ONC
John OylerDirector, Chief Executive OfficerJun 8, 2026
Sale
$270.564,940$1.3M0